Table of Content

1 Alternative to Antibiotics Market Overview
1.1 Product Overview and Scope of Alternative to Antibiotics
1.2 Alternative to Antibiotics Segment by Type
1.2.1 Global Alternative to Antibiotics Market Value Comparison by Type (2024-2034)
1.2.2 Antimicrobial Proteins
1.2.3 Bacteriophages
1.2.4 Probiotics
1.2.5 Other
1.3 Alternative to Antibiotics Segment by Application
1.3.1 Global Alternative to Antibiotics Market Value by Application: (2024-2034)
1.3.2 Food & Beverage
1.3.3 Drugs
1.3.4 Dietary Supplements
1.4 Global Alternative to Antibiotics Market Size Estimates and Forecasts
1.4.1 Global Alternative to Antibiotics Revenue 2018-2034
1.4.2 Global Alternative to Antibiotics Sales 2018-2034
1.4.3 Global Alternative to Antibiotics Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Alternative to Antibiotics Market Competition by Manufacturers
2.1 Global Alternative to Antibiotics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Alternative to Antibiotics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Alternative to Antibiotics Average Price by Manufacturers (2018-2023)
2.4 Global Alternative to Antibiotics Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alternative to Antibiotics, Product Type & Application
2.7 Alternative to Antibiotics Market Competitive Situation and Trends
2.7.1 Alternative to Antibiotics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alternative to Antibiotics Players Market Share by Revenue
2.7.3 Global Alternative to Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alternative to Antibiotics Retrospective Market Scenario by Region
3.1 Global Alternative to Antibiotics Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Alternative to Antibiotics Global Alternative to Antibiotics Sales by Region: 2018-2034
3.2.1 Global Alternative to Antibiotics Sales by Region: 2018-2023
3.2.2 Global Alternative to Antibiotics Sales by Region: 2024-2034
3.3 Global Alternative to Antibiotics Global Alternative to Antibiotics Revenue by Region: 2018-2034
3.3.1 Global Alternative to Antibiotics Revenue by Region: 2018-2023
3.3.2 Global Alternative to Antibiotics Revenue by Region: 2024-2034
3.4 North America Alternative to Antibiotics Market Facts & Figures by Country
3.4.1 North America Alternative to Antibiotics Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Alternative to Antibiotics Sales by Country (2018-2034)
3.4.3 North America Alternative to Antibiotics Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alternative to Antibiotics Market Facts & Figures by Country
3.5.1 Europe Alternative to Antibiotics Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Alternative to Antibiotics Sales by Country (2018-2034)
3.5.3 Europe Alternative to Antibiotics Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alternative to Antibiotics Market Facts & Figures by Country
3.6.1 Asia Pacific Alternative to Antibiotics Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Alternative to Antibiotics Sales by Country (2018-2034)
3.6.3 Asia Pacific Alternative to Antibiotics Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alternative to Antibiotics Market Facts & Figures by Country
3.7.1 Latin America Alternative to Antibiotics Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Alternative to Antibiotics Sales by Country (2018-2034)
3.7.3 Latin America Alternative to Antibiotics Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alternative to Antibiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Alternative to Antibiotics Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Alternative to Antibiotics Sales by Country (2018-2034)
3.8.3 Middle East and Africa Alternative to Antibiotics Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alternative to Antibiotics Sales by Type (2018-2034)
4.1.1 Global Alternative to Antibiotics Sales by Type (2018-2023)
4.1.2 Global Alternative to Antibiotics Sales by Type (2024-2034)
4.1.3 Global Alternative to Antibiotics Sales Market Share by Type (2018-2034)
4.2 Global Alternative to Antibiotics Revenue by Type (2018-2034)
4.2.1 Global Alternative to Antibiotics Revenue by Type (2018-2023)
4.2.2 Global Alternative to Antibiotics Revenue by Type (2024-2034)
4.2.3 Global Alternative to Antibiotics Revenue Market Share by Type (2018-2034)
4.3 Global Alternative to Antibiotics Price by Type (2018-2034)
5 Segment by Application
5.1 Global Alternative to Antibiotics Sales by Application (2018-2034)
5.1.1 Global Alternative to Antibiotics Sales by Application (2018-2023)
5.1.2 Global Alternative to Antibiotics Sales by Application (2024-2034)
5.1.3 Global Alternative to Antibiotics Sales Market Share by Application (2018-2034)
5.2 Global Alternative to Antibiotics Revenue by Application (2018-2034)
5.2.1 Global Alternative to Antibiotics Revenue by Application (2018-2023)
5.2.2 Global Alternative to Antibiotics Revenue by Application (2024-2034)
5.2.3 Global Alternative to Antibiotics Revenue Market Share by Application (2018-2034)
5.3 Global Alternative to Antibiotics Price by Application (2018-2034)
6 Key Companies Profiled
6.1 DSM
6.1.1 DSM Corporation Information
6.1.2 DSM Description and Business Overview
6.1.3 DSM Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 DSM Alternative to Antibiotics Product Portfolio
6.1.5 DSM Recent Developments/Updates
6.2 DuPont(Danisco)
6.2.1 DuPont(Danisco) Corporation Information
6.2.2 DuPont(Danisco) Description and Business Overview
6.2.3 DuPont(Danisco) Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 DuPont(Danisco) Alternative to Antibiotics Product Portfolio
6.2.5 DuPont(Danisco) Recent Developments/Updates
6.3 Chr. Hansen
6.3.1 Chr. Hansen Corporation Information
6.3.2 Chr. Hansen Description and Business Overview
6.3.3 Chr. Hansen Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Chr. Hansen Alternative to Antibiotics Product Portfolio
6.3.5 Chr. Hansen Recent Developments/Updates
6.4 Lallemand
6.4.1 Lallemand Corporation Information
6.4.2 Lallemand Description and Business Overview
6.4.3 Lallemand Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lallemand Alternative to Antibiotics Product Portfolio
6.4.5 Lallemand Recent Developments/Updates
6.5 China-Biotics
6.5.1 China-Biotics Corporation Information
6.5.2 China-Biotics Description and Business Overview
6.5.3 China-Biotics Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 China-Biotics Alternative to Antibiotics Product Portfolio
6.5.5 China-Biotics Recent Developments/Updates
6.6 Nestle
6.6.1 Nestle Corporation Information
6.6.2 Nestle Description and Business Overview
6.6.3 Nestle Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Nestle Alternative to Antibiotics Product Portfolio
6.6.5 Nestle Recent Developments/Updates
6.7 Danone
6.6.1 Danone Corporation Information
6.6.2 Danone Description and Business Overview
6.6.3 Danone Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Danone Alternative to Antibiotics Product Portfolio
6.7.5 Danone Recent Developments/Updates
6.8 Probi
6.8.1 Probi Corporation Information
6.8.2 Probi Description and Business Overview
6.8.3 Probi Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Probi Alternative to Antibiotics Product Portfolio
6.8.5 Probi Recent Developments/Updates
6.9 BioGaia
6.9.1 BioGaia Corporation Information
6.9.2 BioGaia Description and Business Overview
6.9.3 BioGaia Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BioGaia Alternative to Antibiotics Product Portfolio
6.9.5 BioGaia Recent Developments/Updates
6.10 Yakult
6.10.1 Yakult Corporation Information
6.10.2 Yakult Description and Business Overview
6.10.3 Yakult Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Yakult Alternative to Antibiotics Product Portfolio
6.10.5 Yakult Recent Developments/Updates
6.11 Novozymes
6.11.1 Novozymes Corporation Information
6.11.2 Novozymes Alternative to Antibiotics Description and Business Overview
6.11.3 Novozymes Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novozymes Alternative to Antibiotics Product Portfolio
6.11.5 Novozymes Recent Developments/Updates
6.12 Valio
6.12.1 Valio Corporation Information
6.12.2 Valio Alternative to Antibiotics Description and Business Overview
6.12.3 Valio Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Valio Alternative to Antibiotics Product Portfolio
6.12.5 Valio Recent Developments/Updates
6.13 Glory Biotech
6.13.1 Glory Biotech Corporation Information
6.13.2 Glory Biotech Alternative to Antibiotics Description and Business Overview
6.13.3 Glory Biotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Glory Biotech Alternative to Antibiotics Product Portfolio
6.13.5 Glory Biotech Recent Developments/Updates
6.14 Ganeden
6.14.1 Ganeden Corporation Information
6.14.2 Ganeden Alternative to Antibiotics Description and Business Overview
6.14.3 Ganeden Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Ganeden Alternative to Antibiotics Product Portfolio
6.14.5 Ganeden Recent Developments/Updates
6.15 Morinaga Milk Industry
6.15.1 Morinaga Milk Industry Corporation Information
6.15.2 Morinaga Milk Industry Alternative to Antibiotics Description and Business Overview
6.15.3 Morinaga Milk Industry Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Morinaga Milk Industry Alternative to Antibiotics Product Portfolio
6.15.5 Morinaga Milk Industry Recent Developments/Updates
6.16 Sabinsa
6.16.1 Sabinsa Corporation Information
6.16.2 Sabinsa Alternative to Antibiotics Description and Business Overview
6.16.3 Sabinsa Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Sabinsa Alternative to Antibiotics Product Portfolio
6.16.5 Sabinsa Recent Developments/Updates
6.17 Greentech
6.17.1 Greentech Corporation Information
6.17.2 Greentech Alternative to Antibiotics Description and Business Overview
6.17.3 Greentech Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Greentech Alternative to Antibiotics Product Portfolio
6.17.5 Greentech Recent Developments/Updates
6.18 Bioriginal
6.18.1 Bioriginal Corporation Information
6.18.2 Bioriginal Alternative to Antibiotics Description and Business Overview
6.18.3 Bioriginal Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Bioriginal Alternative to Antibiotics Product Portfolio
6.18.5 Bioriginal Recent Developments/Updates
6.19 Biosearch Life
6.19.1 Biosearch Life Corporation Information
6.19.2 Biosearch Life Alternative to Antibiotics Description and Business Overview
6.19.3 Biosearch Life Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Biosearch Life Alternative to Antibiotics Product Portfolio
6.19.5 Biosearch Life Recent Developments/Updates
6.20 UAS Laboratories
6.20.1 UAS Laboratories Corporation Information
6.20.2 UAS Laboratories Alternative to Antibiotics Description and Business Overview
6.20.3 UAS Laboratories Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.20.4 UAS Laboratories Alternative to Antibiotics Product Portfolio
6.20.5 UAS Laboratories Recent Developments/Updates
6.21 Synbiotech
6.21.1 Synbiotech Corporation Information
6.21.2 Synbiotech Alternative to Antibiotics Description and Business Overview
6.21.3 Synbiotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Synbiotech Alternative to Antibiotics Product Portfolio
6.21.5 Synbiotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alternative to Antibiotics Industry Chain Analysis
7.2 Alternative to Antibiotics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alternative to Antibiotics Production Mode & Process
7.4 Alternative to Antibiotics Sales and Marketing
7.4.1 Alternative to Antibiotics Sales Channels
7.4.2 Alternative to Antibiotics Distributors
7.5 Alternative to Antibiotics Customers
8 Alternative to Antibiotics Market Dynamics
8.1 Alternative to Antibiotics Industry Trends
8.2 Alternative to Antibiotics Market Drivers
8.3 Alternative to Antibiotics Market Challenges
8.4 Alternative to Antibiotics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Alternative to Antibiotics Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Alternative to Antibiotics Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Alternative to Antibiotics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Alternative to Antibiotics Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Alternative to Antibiotics Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Alternative to Antibiotics Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Alternative to Antibiotics Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Alternative to Antibiotics Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Alternative to Antibiotics, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alternative to Antibiotics, Product Type & Application
Table 12. Global Key Manufacturers of Alternative to Antibiotics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alternative to Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alternative to Antibiotics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alternative to Antibiotics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Alternative to Antibiotics Sales by Region (2018-2023) & (K Units)
Table 18. Global Alternative to Antibiotics Sales Market Share by Region (2018-2023)
Table 19. Global Alternative to Antibiotics Sales by Region (2024-2034) & (K Units)
Table 20. Global Alternative to Antibiotics Sales Market Share by Region (2024-2034)
Table 21. Global Alternative to Antibiotics Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Alternative to Antibiotics Revenue Market Share by Region (2018-2023)
Table 23. Global Alternative to Antibiotics Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Alternative to Antibiotics Revenue Market Share by Region (2024-2034)
Table 25. North America Alternative to Antibiotics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Alternative to Antibiotics Sales by Country (2018-2023) & (K Units)
Table 27. North America Alternative to Antibiotics Sales by Country (2024-2034) & (K Units)
Table 28. North America Alternative to Antibiotics Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Alternative to Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Alternative to Antibiotics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Alternative to Antibiotics Sales by Country (2018-2023) & (K Units)
Table 32. Europe Alternative to Antibiotics Sales by Country (2024-2034) & (K Units)
Table 33. Europe Alternative to Antibiotics Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Alternative to Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Alternative to Antibiotics Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Alternative to Antibiotics Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Alternative to Antibiotics Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Alternative to Antibiotics Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Alternative to Antibiotics Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Alternative to Antibiotics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Alternative to Antibiotics Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Alternative to Antibiotics Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Alternative to Antibiotics Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Alternative to Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Alternative to Antibiotics Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Alternative to Antibiotics Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Alternative to Antibiotics Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Alternative to Antibiotics Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Alternative to Antibiotics Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Alternative to Antibiotics Sales (K Units) by Type (2018-2023)
Table 51. Global Alternative to Antibiotics Sales (K Units) by Type (2024-2034)
Table 52. Global Alternative to Antibiotics Sales Market Share by Type (2018-2023)
Table 53. Global Alternative to Antibiotics Sales Market Share by Type (2024-2034)
Table 54. Global Alternative to Antibiotics Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Alternative to Antibiotics Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Alternative to Antibiotics Revenue Market Share by Type (2018-2023)
Table 57. Global Alternative to Antibiotics Revenue Market Share by Type (2024-2034)
Table 58. Global Alternative to Antibiotics Price (USD/Unit) by Type (2018-2023)
Table 59. Global Alternative to Antibiotics Price (USD/Unit) by Type (2024-2034)
Table 60. Global Alternative to Antibiotics Sales (K Units) by Application (2018-2023)
Table 61. Global Alternative to Antibiotics Sales (K Units) by Application (2024-2034)
Table 62. Global Alternative to Antibiotics Sales Market Share by Application (2018-2023)
Table 63. Global Alternative to Antibiotics Sales Market Share by Application (2024-2034)
Table 64. Global Alternative to Antibiotics Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Alternative to Antibiotics Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Alternative to Antibiotics Revenue Market Share by Application (2018-2023)
Table 67. Global Alternative to Antibiotics Revenue Market Share by Application (2024-2034)
Table 68. Global Alternative to Antibiotics Price (USD/Unit) by Application (2018-2023)
Table 69. Global Alternative to Antibiotics Price (USD/Unit) by Application (2024-2034)
Table 70. DSM Corporation Information
Table 71. DSM Description and Business Overview
Table 72. DSM Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. DSM Alternative to Antibiotics Product
Table 74. DSM Recent Developments/Updates
Table 75. DuPont(Danisco) Corporation Information
Table 76. DuPont(Danisco) Description and Business Overview
Table 77. DuPont(Danisco) Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. DuPont(Danisco) Alternative to Antibiotics Product
Table 79. DuPont(Danisco) Recent Developments/Updates
Table 80. Chr. Hansen Corporation Information
Table 81. Chr. Hansen Description and Business Overview
Table 82. Chr. Hansen Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Chr. Hansen Alternative to Antibiotics Product
Table 84. Chr. Hansen Recent Developments/Updates
Table 85. Lallemand Corporation Information
Table 86. Lallemand Description and Business Overview
Table 87. Lallemand Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Lallemand Alternative to Antibiotics Product
Table 89. Lallemand Recent Developments/Updates
Table 90. China-Biotics Corporation Information
Table 91. China-Biotics Description and Business Overview
Table 92. China-Biotics Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. China-Biotics Alternative to Antibiotics Product
Table 94. China-Biotics Recent Developments/Updates
Table 95. Nestle Corporation Information
Table 96. Nestle Description and Business Overview
Table 97. Nestle Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Nestle Alternative to Antibiotics Product
Table 99. Nestle Recent Developments/Updates
Table 100. Danone Corporation Information
Table 101. Danone Description and Business Overview
Table 102. Danone Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Danone Alternative to Antibiotics Product
Table 104. Danone Recent Developments/Updates
Table 105. Probi Corporation Information
Table 106. Probi Description and Business Overview
Table 107. Probi Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Probi Alternative to Antibiotics Product
Table 109. Probi Recent Developments/Updates
Table 110. BioGaia Corporation Information
Table 111. BioGaia Description and Business Overview
Table 112. BioGaia Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. BioGaia Alternative to Antibiotics Product
Table 114. BioGaia Recent Developments/Updates
Table 115. Yakult Corporation Information
Table 116. Yakult Description and Business Overview
Table 117. Yakult Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Yakult Alternative to Antibiotics Product
Table 119. Yakult Recent Developments/Updates
Table 120. Novozymes Corporation Information
Table 121. Novozymes Description and Business Overview
Table 122. Novozymes Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Novozymes Alternative to Antibiotics Product
Table 124. Novozymes Recent Developments/Updates
Table 125. Valio Corporation Information
Table 126. Valio Description and Business Overview
Table 127. Valio Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Valio Alternative to Antibiotics Product
Table 129. Valio Recent Developments/Updates
Table 130. Glory Biotech Corporation Information
Table 131. Glory Biotech Description and Business Overview
Table 132. Glory Biotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Glory Biotech Alternative to Antibiotics Product
Table 134. Glory Biotech Recent Developments/Updates
Table 135. Ganeden Corporation Information
Table 136. Ganeden Description and Business Overview
Table 137. Ganeden Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Ganeden Alternative to Antibiotics Product
Table 139. Ganeden Recent Developments/Updates
Table 140. Morinaga Milk Industry Corporation Information
Table 141. Morinaga Milk Industry Description and Business Overview
Table 142. Morinaga Milk Industry Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Morinaga Milk Industry Alternative to Antibiotics Product
Table 144. Morinaga Milk Industry Recent Developments/Updates
Table 145. Sabinsa Corporation Information
Table 146. Sabinsa Description and Business Overview
Table 147. Sabinsa Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Sabinsa Alternative to Antibiotics Product
Table 149. Sabinsa Recent Developments/Updates
Table 150. Greentech Corporation Information
Table 151. Greentech Description and Business Overview
Table 152. Greentech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Greentech Alternative to Antibiotics Product
Table 154. Greentech Recent Developments/Updates
Table 155. Bioriginal Corporation Information
Table 156. Bioriginal Description and Business Overview
Table 157. Bioriginal Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Bioriginal Alternative to Antibiotics Product
Table 159. Bioriginal Recent Developments/Updates
Table 160. Biosearch Life Corporation Information
Table 161. Biosearch Life Description and Business Overview
Table 162. Biosearch Life Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. Biosearch Life Alternative to Antibiotics Product
Table 164. Biosearch Life Recent Developments/Updates
Table 165. UAS Laboratories Corporation Information
Table 166. UAS Laboratories Description and Business Overview
Table 167. UAS Laboratories Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 168. UAS Laboratories Alternative to Antibiotics Product
Table 169. UAS Laboratories Recent Developments/Updates
Table 170. Synbiotech Corporation Information
Table 171. Synbiotech Description and Business Overview
Table 172. Synbiotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 173. Synbiotech Alternative to Antibiotics Product
Table 174. Synbiotech Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Alternative to Antibiotics Distributors List
Table 178. Alternative to Antibiotics Customers List
Table 179. Alternative to Antibiotics Market Trends
Table 180. Alternative to Antibiotics Market Drivers
Table 181. Alternative to Antibiotics Market Challenges
Table 182. Alternative to Antibiotics Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alternative to Antibiotics
Figure 2. Global Alternative to Antibiotics Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Alternative to Antibiotics Market Share by Type in 2024 & 2034
Figure 4. Antimicrobial Proteins Product Picture
Figure 5. Bacteriophages Product Picture
Figure 6. Probiotics Product Picture
Figure 7. Other Product Picture
Figure 8. Global Alternative to Antibiotics Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Alternative to Antibiotics Market Share by Application in 2024 & 2034
Figure 10. Food & Beverage
Figure 11. Drugs
Figure 12. Dietary Supplements
Figure 13. Global Alternative to Antibiotics Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Alternative to Antibiotics Market Size (2018-2034) & (US$ Million)
Figure 15. Global Alternative to Antibiotics Sales (2018-2034) & (K Units)
Figure 16. Global Alternative to Antibiotics Average Price (USD/Unit) & (2018-2034)
Figure 17. Alternative to Antibiotics Report Years Considered
Figure 18. Alternative to Antibiotics Sales Share by Manufacturers in 2024
Figure 19. Global Alternative to Antibiotics Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest Alternative to Antibiotics Players: Market Share by Revenue in 2024
Figure 21. Alternative to Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 22. Global Alternative to Antibiotics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 23. North America Alternative to Antibiotics Sales Market Share by Country (2018-2034)
Figure 24. North America Alternative to Antibiotics Revenue Market Share by Country (2018-2034)
Figure 25. United States Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Alternative to Antibiotics Sales Market Share by Country (2018-2034)
Figure 28. Europe Alternative to Antibiotics Revenue Market Share by Country (2018-2034)
Figure 29. Germany Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Alternative to Antibiotics Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Alternative to Antibiotics Revenue Market Share by Region (2018-2034)
Figure 36. China Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. China Taiwan Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Latin America Alternative to Antibiotics Sales Market Share by Country (2018-2034)
Figure 46. Latin America Alternative to Antibiotics Revenue Market Share by Country (2018-2034)
Figure 47. Mexico Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Argentina Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Alternative to Antibiotics Sales Market Share by Country (2018-2034)
Figure 51. Middle East & Africa Alternative to Antibiotics Revenue Market Share by Country (2018-2034)
Figure 52. Turkey Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. UAE Alternative to Antibiotics Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Alternative to Antibiotics by Type (2018-2034)
Figure 56. Global Revenue Market Share of Alternative to Antibiotics by Type (2018-2034)
Figure 57. Global Alternative to Antibiotics Price (USD/Unit) by Type (2018-2034)
Figure 58. Global Sales Market Share of Alternative to Antibiotics by Application (2018-2034)
Figure 59. Global Revenue Market Share of Alternative to Antibiotics by Application (2018-2034)
Figure 60. Global Alternative to Antibiotics Price (USD/Unit) by Application (2018-2034)
Figure 61. Alternative to Antibiotics Value Chain
Figure 62. Alternative to Antibiotics Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed